| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8962888 | Chest | 2018 | 24 Pages |
Abstract
In patients with PAH receiving treatment with a parenteral prostanoid, survival was significantly associated with the number of guideline-recommended lower risk and higher risk criteria achieved at first follow-up.
Keywords
RAPHPAHmPAPIPAHNT-proBNP6MWDCHDSvO2SVRPAHCTDBNP6-min walk distanceSVIConnective tissue diseaseCongenital heart diseasesubcutaneousstroke volume indexPVRheritable pulmonary arterial hypertensionPulmonary arterial hypertensionmean pulmonary arterial pressureRight Atrial PressureSystemic vascular resistancePulmonary vascular resistanceBiomarkersIdiopathic pulmonary arterial hypertensionbrain natriuretic peptideN-terminal pro-brain natriuretic peptide
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Sonja D. MD, Namita MD, Trushil G. MD, Kim MD, Fernando MD, Kelly M. MD,